Report cover image

Global Desloratadine Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2020-2031

Publisher APO Research, Inc.
Published Jul 08, 2025
Length 190 Pages
SKU # APRC20278363

Description

Summary

According to APO Research, The global Desloratadine Tablets market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Desloratadine Tablets is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Desloratadine Tablets is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for Desloratadine Tablets is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Desloratadine Tablets is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Desloratadine Tablets include Zhejiang China Resources Sanjiu Zhongyi Pharmaceutical, Yangtze River Pharmaceutical Group, Shenzhen Salubris Pharmaceuticals, Guangdong Jiuming pharmaceutical, Yingtai Pharma, Poly Pharm, Sinopharm Group Pharmaceuticals, FangYuan Pharmaceutical and Torrent Pharmaceuticals, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Desloratadine Tablets, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020-2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Desloratadine Tablets, also provides the sales of main regions and countries. Of the upcoming market potential for Desloratadine Tablets, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Desloratadine Tablets sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Desloratadine Tablets market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Desloratadine Tablets sales, projected growth trends, production technology, application and end-user industry.

Desloratadine Tablets Segment by Company

Zhejiang China Resources Sanjiu Zhongyi Pharmaceutical
Yangtze River Pharmaceutical Group
Shenzhen Salubris Pharmaceuticals
Guangdong Jiuming pharmaceutical
Yingtai Pharma
Poly Pharm
Sinopharm Group Pharmaceuticals
FangYuan Pharmaceutical
Torrent Pharmaceuticals
Teva Pharmaceutical Industries
Sun Pharmaceutical Industries
Sandoz International GmbH
Perrigo Company plc
Organon Pharma
Mylan
Glenmark Pharmaceuticals
Dr. Reddy's Laboratories
Apotex
Desloratadine Tablets Segment by Type

Ordinary Tablets
Dispersible Tablets
Other
Desloratadine Tablets Segment by Application

Specialist Medical Centre
Hospital and Clinic
Retail Pharmacies
Other
Desloratadine Tablets Segment by Region

North America

United States
Canada
Mexico
Europe

Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific

China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America

Brazil
Argentina
Chile
Middle East & Africa

Egypt
South Africa
Israel
Türkiye
GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Desloratadine Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Desloratadine Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Desloratadine Tablets.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Desloratadine Tablets market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2020-2031).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Desloratadine Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Desloratadine Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Desloratadine Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

190 Pages
1 Market Overview
1.1 Product Definition
1.2 Global Desloratadine Tablets Market Size, 2020 VS 2024 VS 2031
1.3 Global Desloratadine Tablets Market Size Estimates and Forecasts (2020-2031)
1.4 Global Desloratadine Tablets Sales Estimates and Forecasts (2020-2031)
1.5 Global Desloratadine Tablets Market Average Price (2020-2031)
1.6 Assumptions and Limitations
1.7 Study Goals and Objectives
2 Global Desloratadine Tablets Market Dynamics
2.1 Desloratadine Tablets Industry Trends
2.2 Desloratadine Tablets Industry Drivers
2.3 Desloratadine Tablets Industry Opportunities and Challenges
2.4 Desloratadine Tablets Industry Restraints
3 Desloratadine Tablets Market by Manufacturers
3.1 Global Desloratadine Tablets Revenue by Manufacturers (2020-2025)
3.2 Global Desloratadine Tablets Sales by Manufacturers (2020-2025)
3.3 Global Desloratadine Tablets Average Sales Price by Manufacturers (2020-2025)
3.4 Global Desloratadine Tablets Industry Manufacturers Ranking, 2023 VS 2024 VS 2025
3.5 Global Desloratadine Tablets Key Manufacturers Manufacturing Sites & Headquarters
3.6 Global Desloratadine Tablets Manufacturers, Product Type & Application
3.7 Global Desloratadine Tablets Manufacturers Establishment Date
3.8 Market Competitive Analysis
3.8.1 Global Desloratadine Tablets Market CR5 and HHI
3.8.2 Global Top 5 and 10 Desloratadine Tablets Players Market Share by Revenue in 2024
3.8.3 2024 Desloratadine Tablets Tier 1, Tier 2, and Tier 3
4 Desloratadine Tablets Market by Type
4.1 Desloratadine Tablets Type Introduction
4.1.1 Ordinary Tablets
4.1.2 Dispersible Tablets
4.1.3 Other
4.2 Global Desloratadine Tablets Sales by Type
4.2.1 Global Desloratadine Tablets Sales by Type (2020 VS 2024 VS 2031)
4.2.2 Global Desloratadine Tablets Sales by Type (2020-2031)
4.2.3 Global Desloratadine Tablets Sales Market Share by Type (2020-2031)
4.3 Global Desloratadine Tablets Revenue by Type
4.3.1 Global Desloratadine Tablets Revenue by Type (2020 VS 2024 VS 2031)
4.3.2 Global Desloratadine Tablets Revenue by Type (2020-2031)
4.3.3 Global Desloratadine Tablets Revenue Market Share by Type (2020-2031)
5 Desloratadine Tablets Market by Application
5.1 Desloratadine Tablets Application Introduction
5.1.1 Specialist Medical Centre
5.1.2 Hospital and Clinic
5.1.3 Retail Pharmacies
5.1.4 Other
5.2 Global Desloratadine Tablets Sales by Application
5.2.1 Global Desloratadine Tablets Sales by Application (2020 VS 2024 VS 2031)
5.2.2 Global Desloratadine Tablets Sales by Application (2020-2031)
5.2.3 Global Desloratadine Tablets Sales Market Share by Application (2020-2031)
5.3 Global Desloratadine Tablets Revenue by Application
5.3.1 Global Desloratadine Tablets Revenue by Application (2020 VS 2024 VS 2031)
5.3.2 Global Desloratadine Tablets Revenue by Application (2020-2031)
5.3.3 Global Desloratadine Tablets Revenue Market Share by Application (2020-2031)
6 Global Desloratadine Tablets Sales by Region
6.1 Global Desloratadine Tablets Sales by Region: 2020 VS 2024 VS 2031
6.2 Global Desloratadine Tablets Sales by Region (2020-2031)
6.2.1 Global Desloratadine Tablets Sales by Region (2020-2025)
6.2.2 Global Desloratadine Tablets Sales Forecasted by Region (2025-2030)
6.3 North America
6.3.1 North America Desloratadine Tablets Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.3.2 North America Desloratadine Tablets Sales by Country (2020-2031)
6.3.3 U.S.
6.3.4 Canada
6.3.5 Mexico
6.4 Europe
6.4.1 Europe Desloratadine Tablets Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.4.2 Europe Desloratadine Tablets Sales by Country (2020-2031)
6.4.3 Germany
6.4.4 France
6.4.5 U.K.
6.4.6 Italy
6.4.7 Netherlands
6.5 Asia Pacific
6.5.1 Asia Pacific Desloratadine Tablets Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.5.2 Asia Pacific Desloratadine Tablets Sales by Country (2020-2031)
6.5.3 China
6.5.4 Japan
6.5.5 South Korea
6.5.6 Southeast Asia
6.5.7 India
6.5.8 Australia
6.6 South America, Middle East and Africa
6.6.1 South America, Middle East and Africa Desloratadine Tablets Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.6.2 South America, Middle East and Africa Desloratadine Tablets Sales by Country (2020-2031)
6.6.3 Brazil
6.6.4 South Africa
6.6.5 Saudi Arabia
6.6.6 Turkey
6.6.6 Argentina
6.6.6 UAE
6.6.6 Egypt
6.6.6 Chile
7 Global Desloratadine Tablets Revenue by Region
7.1 Global Desloratadine Tablets Revenue by Region
7.1.1 Global Desloratadine Tablets Revenue by Region: 2020 VS 2024 VS 2031
7.1.2 Global Desloratadine Tablets Revenue by Region (2020-2025)
7.1.3 Global Desloratadine Tablets Revenue by Region (2026-2031)
7.1.4 Global Desloratadine Tablets Revenue Market Share by Region (2020-2031)
7.2 North America
7.2.1 North America Desloratadine Tablets Revenue (2020-2031)
7.2.2 North America Desloratadine Tablets Revenue Share by Country: 2020 VS 2024 VS 2031
7.3 Europe
7.3.1 Europe Desloratadine Tablets Revenue (2020-2031)
7.3.2 Europe Desloratadine Tablets Revenue Share by Country: 2020 VS 2024 VS 2031
7.4 Asia-Pacific
7.4.1 Asia-Pacific Desloratadine Tablets Revenue (2020-2031)
7.4.2 Asia-Pacific Desloratadine Tablets Revenue Share by Country: 2020 VS 2024 VS 2031
7.5 South America, Middle East and Africa
7.5.1 South America, Middle East and Africa Desloratadine Tablets Revenue (2020-2031)
7.5.2 South America, Middle East and Africa Desloratadine Tablets Revenue Share by Country: 2020 VS 2024 VS 2031
8 Company Profiles
8.1 Zhejiang China Resources Sanjiu Zhongyi Pharmaceutical
8.1.1 Zhejiang China Resources Sanjiu Zhongyi Pharmaceutical Comapny Information
8.1.2 Zhejiang China Resources Sanjiu Zhongyi Pharmaceutical Business Overview
8.1.3 Zhejiang China Resources Sanjiu Zhongyi Pharmaceutical Desloratadine Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
8.1.4 Zhejiang China Resources Sanjiu Zhongyi Pharmaceutical Desloratadine Tablets Product Portfolio
8.1.5 Zhejiang China Resources Sanjiu Zhongyi Pharmaceutical Recent Developments
8.2 Yangtze River Pharmaceutical Group
8.2.1 Yangtze River Pharmaceutical Group Comapny Information
8.2.2 Yangtze River Pharmaceutical Group Business Overview
8.2.3 Yangtze River Pharmaceutical Group Desloratadine Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
8.2.4 Yangtze River Pharmaceutical Group Desloratadine Tablets Product Portfolio
8.2.5 Yangtze River Pharmaceutical Group Recent Developments
8.3 Shenzhen Salubris Pharmaceuticals
8.3.1 Shenzhen Salubris Pharmaceuticals Comapny Information
8.3.2 Shenzhen Salubris Pharmaceuticals Business Overview
8.3.3 Shenzhen Salubris Pharmaceuticals Desloratadine Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
8.3.4 Shenzhen Salubris Pharmaceuticals Desloratadine Tablets Product Portfolio
8.3.5 Shenzhen Salubris Pharmaceuticals Recent Developments
8.4 Guangdong Jiuming pharmaceutical
8.4.1 Guangdong Jiuming pharmaceutical Comapny Information
8.4.2 Guangdong Jiuming pharmaceutical Business Overview
8.4.3 Guangdong Jiuming pharmaceutical Desloratadine Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
8.4.4 Guangdong Jiuming pharmaceutical Desloratadine Tablets Product Portfolio
8.4.5 Guangdong Jiuming pharmaceutical Recent Developments
8.5 Yingtai Pharma
8.5.1 Yingtai Pharma Comapny Information
8.5.2 Yingtai Pharma Business Overview
8.5.3 Yingtai Pharma Desloratadine Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
8.5.4 Yingtai Pharma Desloratadine Tablets Product Portfolio
8.5.5 Yingtai Pharma Recent Developments
8.6 Poly Pharm
8.6.1 Poly Pharm Comapny Information
8.6.2 Poly Pharm Business Overview
8.6.3 Poly Pharm Desloratadine Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
8.6.4 Poly Pharm Desloratadine Tablets Product Portfolio
8.6.5 Poly Pharm Recent Developments
8.7 Sinopharm Group Pharmaceuticals
8.7.1 Sinopharm Group Pharmaceuticals Comapny Information
8.7.2 Sinopharm Group Pharmaceuticals Business Overview
8.7.3 Sinopharm Group Pharmaceuticals Desloratadine Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
8.7.4 Sinopharm Group Pharmaceuticals Desloratadine Tablets Product Portfolio
8.7.5 Sinopharm Group Pharmaceuticals Recent Developments
8.8 FangYuan Pharmaceutical
8.8.1 FangYuan Pharmaceutical Comapny Information
8.8.2 FangYuan Pharmaceutical Business Overview
8.8.3 FangYuan Pharmaceutical Desloratadine Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
8.8.4 FangYuan Pharmaceutical Desloratadine Tablets Product Portfolio
8.8.5 FangYuan Pharmaceutical Recent Developments
8.9 Torrent Pharmaceuticals
8.9.1 Torrent Pharmaceuticals Comapny Information
8.9.2 Torrent Pharmaceuticals Business Overview
8.9.3 Torrent Pharmaceuticals Desloratadine Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
8.9.4 Torrent Pharmaceuticals Desloratadine Tablets Product Portfolio
8.9.5 Torrent Pharmaceuticals Recent Developments
8.10 Teva Pharmaceutical Industries
8.10.1 Teva Pharmaceutical Industries Comapny Information
8.10.2 Teva Pharmaceutical Industries Business Overview
8.10.3 Teva Pharmaceutical Industries Desloratadine Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
8.10.4 Teva Pharmaceutical Industries Desloratadine Tablets Product Portfolio
8.10.5 Teva Pharmaceutical Industries Recent Developments
8.11 Sun Pharmaceutical Industries
8.11.1 Sun Pharmaceutical Industries Comapny Information
8.11.2 Sun Pharmaceutical Industries Business Overview
8.11.3 Sun Pharmaceutical Industries Desloratadine Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
8.11.4 Sun Pharmaceutical Industries Desloratadine Tablets Product Portfolio
8.11.5 Sun Pharmaceutical Industries Recent Developments
8.12 Sandoz International GmbH
8.12.1 Sandoz International GmbH Comapny Information
8.12.2 Sandoz International GmbH Business Overview
8.12.3 Sandoz International GmbH Desloratadine Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
8.12.4 Sandoz International GmbH Desloratadine Tablets Product Portfolio
8.12.5 Sandoz International GmbH Recent Developments
8.13 Perrigo Company plc
8.13.1 Perrigo Company plc Comapny Information
8.13.2 Perrigo Company plc Business Overview
8.13.3 Perrigo Company plc Desloratadine Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
8.13.4 Perrigo Company plc Desloratadine Tablets Product Portfolio
8.13.5 Perrigo Company plc Recent Developments
8.14 Organon Pharma
8.14.1 Organon Pharma Comapny Information
8.14.2 Organon Pharma Business Overview
8.14.3 Organon Pharma Desloratadine Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
8.14.4 Organon Pharma Desloratadine Tablets Product Portfolio
8.14.5 Organon Pharma Recent Developments
8.15 Mylan
8.15.1 Mylan Comapny Information
8.15.2 Mylan Business Overview
8.15.3 Mylan Desloratadine Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
8.15.4 Mylan Desloratadine Tablets Product Portfolio
8.15.5 Mylan Recent Developments
8.16 Glenmark Pharmaceuticals
8.16.1 Glenmark Pharmaceuticals Comapny Information
8.16.2 Glenmark Pharmaceuticals Business Overview
8.16.3 Glenmark Pharmaceuticals Desloratadine Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
8.16.4 Glenmark Pharmaceuticals Desloratadine Tablets Product Portfolio
8.16.5 Glenmark Pharmaceuticals Recent Developments
8.17 Dr. Reddy's Laboratories
8.17.1 Dr. Reddy's Laboratories Comapny Information
8.17.2 Dr. Reddy's Laboratories Business Overview
8.17.3 Dr. Reddy's Laboratories Desloratadine Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
8.17.4 Dr. Reddy's Laboratories Desloratadine Tablets Product Portfolio
8.17.5 Dr. Reddy's Laboratories Recent Developments
8.18 Apotex
8.18.1 Apotex Comapny Information
8.18.2 Apotex Business Overview
8.18.3 Apotex Desloratadine Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
8.18.4 Apotex Desloratadine Tablets Product Portfolio
8.18.5 Apotex Recent Developments
9 Value Chain and Sales Channels Analysis
9.1 Desloratadine Tablets Value Chain Analysis
9.1.1 Desloratadine Tablets Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Desloratadine Tablets Production Mode & Process
9.2 Desloratadine Tablets Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Desloratadine Tablets Distributors
9.2.3 Desloratadine Tablets Customers
10 Concluding Insights
11 Appendix
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
11.6 Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.